ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer

NCT00056537 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small-Cell Lung Carcinoma
Renal Cell Carcinoma
Pancreatic Cancer

Interventions

DRUG: ABR-217620

Sponsor

Active Biotech AB